How to Avoid Desk Rejection at International Journal of Biological Macromolecules

The most common failure pattern is chemistry trying to wear a biological-macromolecules badge without earning it. We often see decent structural characterization, basic assay work, and broad application claims, but the manuscript still does not prove a real structure-function argument or genuine biological relevance. The submissions that survive triage more often make clear that the macromolecule is biologically meaningful, the characterization is complete enough to trust, and the assay logic goes beyond generic screening.

Insufficient molecular characterization accounts for about 40% of early rejections. Authors submit polysaccharide research without proper sugar analysis, or protein studies without adequate purity assessment. Common mistake? Submitting papers with only FTIR and basic NMR data for complex carbohydrate structures, when IJBM expects detailed compositional analysis and linkage studies.

Poor biological relevance kills another 25% of submissions. Authors submit synthetic polymer chemistry and try to frame it as biological macromolecules research without establishing genuine biological connections (the biological connection needs to be real and demonstrated, not theoretical speculation).

Methodological inadequacy around biological assays rejects about 20% of papers. Too many submissions use outdated or inappropriate methods for biological activity assessment; generic DPPH antioxidant assays for polysaccharides won't survive editorial screening when more sophisticated mechanistic assays are available.

Scope mismatch represents another major trigger. Papers that belong in materials science or synthetic chemistry journals get submitted to IJBM without adequate biological focus.

Poor experimental design rounds out the common triggers: inadequate controls, insufficient replication, or statistical analysis problems. The pattern? Authors treating IJBM like a general chemistry journal rather than recognizing it as a specialized biological macromolecules venue where the bar for biological relevance is higher.

Statistical inadequacy often compounds these problems (sample sizes that work for chemical characterization don't meet standards for biological studies).

Synthetic polymer research without clear biological relevance struggles at IJBM every time.

If your work focuses primarily on synthetic methodology or materials properties without demonstrated biological activity, consider Molecules Impact Factor 2026: Ranking, Quartile & What It Means or similar chemistry journals instead (materials properties alone can justify publication there).

Basic characterization studies without functional data rarely survive editorial screening. Simply isolating and characterizing a natural polysaccharide or protein without biological activity assessment won't meet current editorial standards; the journal expects structure-function relationships, not just structural determination.

Review articles without substantial new synthesis get rejected quickly. Before writing a review, check recent IJBM review articles to understand the expected depth and analytical approach.

Successful example: Chitosan modification study included degree of substitution analysis through multiple analytical techniques; molecular weight determination using GPC and light scattering; NMR structural confirmation of modification sites; antimicrobial testing against multiple bacterial strains with MIC determination; biofilm inhibition assays with quantitative assessment; and cytotoxicity evaluation using appropriate cell lines. Authors connected specific structural modifications to enhanced antimicrobial activity through membrane disruption mechanisms (supported by mechanistic studies including membrane permeability assays and microscopic analysis).

Desk rejection example: Polysaccharide extraction and basic characterization study included sugar composition analysis and FTIR spectroscopy but no biological activity testing whatsoever. Authors claimed potential antioxidant applications based on literature precedent without experimental validation of their specific polysaccharide's bioactivity. Without biological data, editors could not evaluate biological relevance. Why publish this in a biological macromolecules journal rather than a natural products extraction journal?

Borderline case that succeeded: Protein structural modification study initially lacked biological activity data but included detailed structural analysis and demonstrated that modifications affected protein stability and folding in ways relevant to biological function. Authors revised to include basic bioactivity screening that supported their structural findings.

What do successful papers share? Thorough structural analysis using state-of-the-art techniques; meaningful biological activity assessment that goes beyond screening assays; and clear connections between macromolecular structure and biological function. They read like genuine biological macromolecules research rather than chemistry work with biological components added to match journal scope.

For more context on editorial rejection patterns, see Desk Rejection: What It Means, Why It Happens, and What to Do Next.

A IJBM desk-rejection risk check can flag the desk-rejection triggers covered above before your paper reaches the editor.